Allterum Therapeutics

About:

Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers.

Top Investors: Cancer Prevention and Research Institute of Texas, Fannin Innovation Studio

Description:

Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.

Total Funding Amount:

$16.7M

Headquarters Location:

Houston, Texas, United States

Founded Date:

2018-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-04-08

IPO Status:

Private

Industries: